Investor's Business Daily on MSN
Apellis Pharmaceuticals shows rising relative price performance; still shy of key benchmark
Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...
This year saw 11% fewer store openings than last year, but Coresight Research is tracking more planned openings than closings ...
Stocks edged lower on Wall Street as trading for 2025 nudges closer to the finish line. The S&P 500 fell 0.1% Tuesday. The ...
Stocks on Wall Street are largely unchanged as trading for 2025 nudges closer to the finish line. The Dow dipped 0.3% while ...
Chinese factory activity expanded for the first time in eight months in December, as orders picked up ahead of holidays and ...
3hon MSN
China Vanke's near-default exposes fragility of the faltering recovery in the property industry
State-backed property developer China Vanke, once the country’s largest homebuilder by sales, narrowly avoided defaulting on ...
Some records are better left unbroken. Nobody wants the record for most times left at the altar, or to put it into 2025 terms, no worker wants to wear the crown of "person laid off the most in the ...
Marvell Technology stock jumped after the company forecast stronger-than-expected growth in its data-center segment, boosting confidence in its custom chip business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback